Génomique du cancer du sein appliquée aux traitements
- 26 October 2018
- journal article
- Published by Elsevier BV in Revue Francophone des Laboratoires
- Vol. 2018 (506), 52-60
- https://doi.org/10.1016/s1773-035x(18)30323-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Classification, Treatment Strategy, and Associated Drug Resistance in Breast CancerClinical Breast Cancer, 2016
- Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancerBritish Journal of Cancer, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15Breast Cancer Research, 2013
- A refined molecular taxonomy of breast cancerOncogene, 2011
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJCI Insight, 2011
- Molecular Stratification of Triple-Negative Breast CancersThe Oncologist, 2011
- Identification of molecular apocrine breast tumours by microarray analysisOncogene, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002